艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688488 艾迪药业

已收盘 06-17 15:00:00

{"stockData":{"symbol":"688488","market":"SH","secType":"STK","nameCN":"艾迪药业","latestPrice":12.98,"timestamp":1718607600000,"preClose":12.61,"halted":0,"volume":3058751,"delay":0,"floatShares":421000000,"shares":421000000,"eps":-0.2143,"marketStatus":"已收盘","marketStatusCode":5,"change":0.37,"latestTime":"06-17 15:00:00","open":12.31,"high":13.1,"low":12.31,"amount":39269900,"amplitude":0.0626,"askPrice":12.98,"askSize":153,"bidPrice":12.96,"bidSize":90,"shortable":0,"etf":0,"ttmEps":-0.2143,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1718674200000},"adr":0,"adjPreClose":12.61,"symbolType":"stock_kcb","openAndCloseTimeList":[[1718587800000,1718595000000],[1718600400000,1718607600000]],"highLimit":13.87,"lowLimit":11.35,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":420782808,"pbRate":4.9,"roa":"--","roe":"--","epsLYR":-0.18,"committee":-0.754777,"marketValue":5462000000,"floatMarketCap":5462000000,"peRate":-60.569294,"changeRate":0.0293,"turnoverRate":0.0073,"status":0,"afterMarket":{"amount":0,"volume":0,"close":12.98,"buyVolume":0,"sellVolume":0,"time":1718609639037,"indexStatus":"已收盘 06-17 15:30:00","preClose":12.61}},"requestUrl":"/m/hq/s/688488/tweets","defaultTab":"tweets","newsList":[{"id":"2443546122","title":"新冠药物概念盘中跳水，艾迪药业跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443546122","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443546122?lang=zh_cn&edition=full","pubTime":"2024-06-13 09:51","pubTimestamp":1718243503,"startTime":"0","endTime":"0","summary":"06月13日，新冠药物概念盘中跳水，截至09点51分，新冠药物概念整体指数下跌1.02%，报477.080点。从个股上来看，该概念的成分股中，艾迪药业跌0.39%，拓新药业、君实生物-U、美诺华跌幅居前。从资金上来看，截止发稿，新冠药物概念主力净流入为-5989.74万，其中星湖科技受到资金热捧，主力净流入1462.88万；拉长时间线来看，该板块近20日主力资金净流入-40.11亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613095143af8d4df8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613095143af8d4df8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2442214379","title":"艾迪药业创近3月新低 近8家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2442214379","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442214379?lang=zh_cn&edition=full","pubTime":"2024-06-12 10:01","pubTimestamp":1718157701,"startTime":"0","endTime":"0","summary":"06月12日，艾迪药业股价大幅下跌，截至10点01分，艾迪药业下跌5.01%，报12.90元/股，创近3月新低，成交1807万元，换手率0.33%，振幅4.93%。资金动向截止发稿，艾迪药业获得主力净流出113万元，其中超大单流出181万元，大单流入69万元。北向资金方面，艾迪药业06月11日获得北向资金增持52.03万股，连续4日增持，截至06月11日，北向资金当前共持有艾迪药业139.43万股，市值1798万元，持股占流通股比为0.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612100944af8d11af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612100944af8d11af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2442358555","title":"艾迪药业06月11日主力资金流出701万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2442358555","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442358555?lang=zh_cn&edition=full","pubTime":"2024-06-11 15:18","pubTimestamp":1718090335,"startTime":"0","endTime":"0","summary":"06月11日, 艾迪药业股价涨1.34%，报收13.58元，成交金额6154万元，换手率1.08%，振幅6.34%，量比1.98。艾迪药业今日主力资金净流出701万元，连续5日净流出，上一交易日主力净流出505万元，今日环比增加38.81%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为28.57%，平均跌幅为2.95%。该股近5个交易日下跌7.43%，主力资金累计净流出1569万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入115万元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406111530199f301062&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406111530199f301062&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2442980776","title":"北向资金6月7日净买入艾迪药业21.77万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2442980776","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442980776?lang=zh_cn&edition=full","pubTime":"2024-06-11 09:30","pubTimestamp":1718069441,"startTime":"0","endTime":"0","summary":"6月7日, 北向资金增持艾迪药业21.77万股，连续3日增持。截止当日收盘，沪股通共持有艾迪药业87.40万股，占流通股0.20%。沪股通增持金额前五个股分别为工业富联、XD晶科能、建设银行、中国银行、长江电力。艾迪药业近5个交易日下跌11.32%，沪股通累计增持25.20万股；近20个交易日下跌21.32%，沪股通累计减持45.12万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406110935229f2f18e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406110935229f2f18e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2441033121","title":"艾迪药业06月07日遭主力抛售505万元 环比增加195.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441033121","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441033121?lang=zh_cn&edition=full","pubTime":"2024-06-07 15:19","pubTimestamp":1717744783,"startTime":"0","endTime":"0","summary":"06月07日, 艾迪药业股价跌3.60%，报收13.40元，成交金额4003万元，换手率0.70%，振幅5.54%，量比1.26。艾迪药业今日主力资金净流出505万元，连续4日净流出，上一交易日主力净流出171万元，今日环比增加195.32%。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为62.50%，平均跌幅为2.55%。该股近5个交易日下跌11.32%，主力资金累计净流出559万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入480万元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071537369f236309&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071537369f236309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2441085729","title":"艾迪药业(688488)：深耕HIV治疗领域 艾诺米替片纳入医保进入销售放量阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2441085729","media":"天风证券","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441085729?lang=zh_cn&edition=full","pubTime":"2024-06-07 12:54","pubTimestamp":1717736060,"startTime":"0","endTime":"0","summary":"复方制剂艾诺米替成功纳入医保目录，有望迎来销售放量我国艾滋病治疗患者规模持续扩大，长期用药需求仍有较大增长空间。艾诺米替片于2022 年12 月30 日获批上市，并成功进入2023年医保目录，医保支付范围为限艾滋病病毒感染，可用于HIV 患者的初治。抗HIV 创新药艾诺韦林片和艾诺米替片在上市后持续放量，HIV 创新药销售额已逐步填补费用投入，日后有望成为主要营收来源。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071254219f22ed62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071254219f22ed62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2441761479","title":"艾迪药业06月06日主力资金流出171万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2441761479","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441761479?lang=zh_cn&edition=full","pubTime":"2024-06-06 15:18","pubTimestamp":1717658307,"startTime":"0","endTime":"0","summary":"06月06日, 艾迪药业股价跌4.66%，报收13.90元，成交金额3835万元，换手率0.65%，振幅5.83%，量比1.41。艾迪药业今日主力资金净流出171万元，连续3日净流出，上一交易日主力净流出93万元，今日环比增加83.87%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为56.25%，平均跌幅为1.65%。该股近5个交易日下跌5.70%，主力资金累计净流出186万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1529万元，其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406061531119f1f8ab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406061531119f1f8ab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2441575343","title":"艾迪药业创近1月新低 近7家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2441575343","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441575343?lang=zh_cn&edition=full","pubTime":"2024-06-06 11:09","pubTimestamp":1717643340,"startTime":"0","endTime":"0","summary":"06月06日，艾迪药业股价大幅下跌，截至11点09分，艾迪药业下跌5.21%，报13.82元/股，创近1月新低，成交1953万元，换手率0.33%，振幅5.21%。北向资金方面，艾迪药业06月05日获得北向资金增持2.60万股，截至06月05日，北向资金当前共持有艾迪药业52.91万股，市值731万元，持股占流通股比为0.12%。主营业务及业绩艾迪药业公司主营业务为探索、研发和销售创新性化学药物以及人源蛋白产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606110917aef3b232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606110917aef3b232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2440619294","title":"艾迪药业最新公告：艾诺韦林原料药获得上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2440619294","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440619294?lang=zh_cn&edition=full","pubTime":"2024-06-03 19:29","pubTimestamp":1717414165,"startTime":"0","endTime":"0","summary":"艾迪药业公告，公司全资子公司扬州艾迪医药科技有限公司(统称“艾迪药业”或“公司”)收到国家药品监督管理局签发的“艾诺韦林”《化学原料药上市申请批准通知书》。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300025238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2440656864","title":"艾迪药业(688488.SH)：艾诺韦林原料药获得上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2440656864","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440656864?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:40","pubTimestamp":1717411209,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪药业(688488.SH)公告，公司收到国家药品监督管理局签发的“艾诺韦林”《化学原料药上市申请批准通知书》，化学原料药名称为艾诺韦林(Ainuovirine)。据悉，艾诺韦林原料药对应的制剂为公司两款抗HIV领域创新药——艾诺韦林片以及艾诺米替片，其中艾诺韦林片是中国首个批准上市的治疗HIV-1感染者的口服1类新药;艾诺米替片是在艾诺韦林片的基础上，加入两个核苷类逆转录酶抑制剂——富马酸替诺福韦二吡呋酯和拉米夫定所组成的三联单片复方抗艾滋病1类新药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2440468245","title":"艾迪药业最新公告：拟签署日常经营相关协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2440468245","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440468245?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:10","pubTimestamp":1717409422,"startTime":"0","endTime":"0","summary":"艾迪药业公告，为满足人源蛋白在研项目后续研发需要，公司拟就向南京南大药业有限责任公司购买人源蛋白原料药、并向其销售人源蛋白粗品等原辅料包材签署相关协议，董事会授权管理层在不超过300万元人民币的额度范围内签署相关协议；授权期限自董事会通过之日起12个月内有效。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300023311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2439937949","title":"艾迪药业上涨5.02% 券商看好增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2439937949","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439937949?lang=zh_cn&edition=full","pubTime":"2024-05-31 13:25","pubTimestamp":1717133129,"startTime":"0","endTime":"0","summary":"05月31日，艾迪药业股价大幅上涨，截至13点25分，艾迪药业上涨5.02%，报15.48元/股，成交3439万元，换手率0.54%。资金动向截止发稿，艾迪药业获得主力净流入195万元，其中超大单流入298万元，大单流出102万元。北向资金方面，艾迪药业05月30日获得北向资金减持1.42万股，截至05月30日，北向资金当前共持有艾迪药业59.51万股，市值921万元，持股占流通股比为0.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531132543aef2b382&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531132543aef2b382&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2438801026","title":"艾迪药业获开源证券买入评级，HIV药物市场持续扩容，创新药艾诺米替有望进一步放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2438801026","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438801026?lang=zh_cn&edition=full","pubTime":"2024-05-27 17:24","pubTimestamp":1716801862,"startTime":"0","endTime":"0","summary":"5月27日，艾迪药业获开源证券买入评级，近一个月艾迪药业获得2份研报关注。开源证券预计，受益于HIV市场持续扩容，2023年公司抗HIV创新药艾诺韦林片和艾诺米替片的销售初步起量，后续有望进一步放量。同时，公司已于2023年11月向国家药品监督管理局药品审评中心递交艾诺韦林片和艾诺米替片新适应症（针对经治HIV-1感染者）上市许可申请并获受理。研报认为，全球及中国总HIV感染者人数仍处于增长阶段，国家免费抗HIV药物目录更新较慢，医保+自费的抗HIV药物市场规模逐年扩大，为新进入医保目录的HIV药物提供新机遇。风险提示：行业政策变化、HIV新药销售不达预期及竞争格局变动的风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405271724249568112b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405271724249568112b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","688488","161027"],"gpt_icon":0},{"id":"2438371805","title":"开源证券：给予艾迪药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2438371805","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438371805?lang=zh_cn&edition=full","pubTime":"2024-05-27 16:50","pubTimestamp":1716799835,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意近期对艾迪药业进行研究并发布了研究报告《公司首次覆盖报告：HIV药物市场持续扩容，创新药艾诺米替有望进一步放量》，本报告对艾迪药业给出买入评级，当前股价为14.99元。截至2022年，我国报告存活艾滋病感染者122.3万。复方制剂艾诺米替片于2022年12月获批上市并于2023年底纳入医保。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为20.11。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700018841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688488"],"gpt_icon":0},{"id":"2437472362","title":"独家药品概念盘中拉升，艾迪药业涨2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437472362","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437472362?lang=zh_cn&edition=full","pubTime":"2024-05-24 09:43","pubTimestamp":1716514984,"startTime":"0","endTime":"0","summary":"05月24日，独家药品概念盘中拉升，截至09点43分，独家药品概念整体指数上涨0.60%，报875.730点。从个股上来看，该概念的成分股中，艾迪药业涨2.02%，上海医药、舒泰神、甘李药业涨幅居前。从资金上来看，截止发稿，独家药品概念概念主力净流入为-1336.87万，其中甘李药业受到资金热捧，主力净流入866.27万；拉长时间线来看，该板块近20日主力资金净流入-32.02亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524094304941e9cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524094304941e9cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","603087","BK0262"],"gpt_icon":0},{"id":"2437833177","title":"艾迪药业05月23日主力资金流入395万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2437833177","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437833177?lang=zh_cn&edition=full","pubTime":"2024-05-23 15:19","pubTimestamp":1716448756,"startTime":"0","endTime":"0","summary":"05月23日, 艾迪药业股价涨1.16%，报收14.88元，成交金额2654万元，换手率0.43%，振幅3.74%，量比0.67。艾迪药业今日主力资金净流入395万元，连续3日净流入，上一交易日主力净流入205万元，今日环比增加92.68%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为56.25%，平均涨幅为2.49%。该股近5个交易日下跌4.43%，主力资金累计净流入711万元；近20日主力资金累计净流入2446万元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052315384395525997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052315384395525997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2437201815","title":"医保概念盘中跳水，艾迪药业跌0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437201815","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437201815?lang=zh_cn&edition=full","pubTime":"2024-05-23 13:46","pubTimestamp":1716443207,"startTime":"0","endTime":"0","summary":"05月23日，医保概念盘中跳水，截至13点46分，医保概念整体指数下跌2.02%，报1096.940点。从个股上来看，该概念的成分股中，艾迪药业跌0.07%，跌幅居前。从资金上来看，截止发稿，医保概念主力净流入为-6.94亿，其中科伦药业受到资金热捧，主力净流入3766.66万；拉长时间线来看，该板块近20日主力资金净流入-84.95亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523134647af89d46c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523134647af89d46c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2437429632","title":"艾迪药业获得实用新型专利授权：“车载式尿蛋白吸附系统”","url":"https://stock-news.laohu8.com/highlight/detail?id=2437429632","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437429632?lang=zh_cn&edition=full","pubTime":"2024-05-22 01:57","pubTimestamp":1716314223,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示艾迪药业新获得一项实用新型专利授权，专利名为“车载式尿蛋白吸附系统”，专利申请号为CN202322204640.1，授权日为2024年5月7日。本实用新型提供了一种减少尿液托运、降低人工处理工作量以及可有效提升尿液吸附效率的车载式尿蛋白吸附系统。今年以来艾迪药业新获得专利授权3个，较去年同期增加了50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052200000998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2436994112","title":"艾迪药业5月17日获融资净买入121万元 环比增加298.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436994112","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436994112?lang=zh_cn&edition=full","pubTime":"2024-05-20 10:00","pubTimestamp":1716170406,"startTime":"0","endTime":"0","summary":"5月17日，艾迪药业获融资净买入121万元，环比上一交易日增加298.46%。其中，融资买入329万元，融资偿还207万元。融券方面，融券卖出0.00万股，当前融券余量为3.03万股。A股市场共有1586股获融资净买入，艾迪药业净买入额排名第399。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520100018877be3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520100018877be3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2435152316","title":"北向资金5月14日净卖出艾迪药业11.06万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2435152316","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435152316?lang=zh_cn&edition=full","pubTime":"2024-05-16 09:30","pubTimestamp":1715823043,"startTime":"0","endTime":"0","summary":"5月14日，北向资金减持艾迪药业11.06万股连续3日减持。截止当日收盘，沪股通共持有艾迪药业72.00万股，占流通股0.17%。沪股通减持金额前五个股分别为洛阳钼业、药明康德、工商银行、农业银行、宇通客车。艾迪药业近5个交易日下跌1.85%，沪股通累计减持62.55万股；近20个交易日下跌0.31%，沪股通累计增持11.39万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240516093714876e5363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240516093714876e5363&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-20","address":"江苏省扬州市邗江区新甘泉西路69号","stockEarnings":[{"period":"1week","weight":-0.0313},{"period":"1month","weight":-0.1571},{"period":"3month","weight":-0.1505},{"period":"6month","weight":0.0527},{"period":"1year","weight":-0.0107},{"period":"ytd","weight":0.0376}],"companyName":"江苏艾迪药业股份有限公司","boardCode":"AI0041","perCapita":"51084股","boardName":"其他制造业","registeredCapital":"42078万元","compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0438},{"period":"3month","weight":-0.0153},{"period":"6month","weight":0.0392},{"period":"1year","weight":-0.0786},{"period":"ytd","weight":0.0138}],"survey":"　　江苏艾迪药业股份有限公司主营业务以为HIV为主的抗病毒业务及人源蛋白业务。主要产品有乌司他丁、尤瑞克林、尿激酶等人源蛋白产品以及蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等制剂。公司荣获“2023年度扬州民营企业创新20强”、荣登“2022年度扬州市创新型企业50强”名单及“2022年度中国小分子药物企业创新力TOP30排行榜”。","serverTime":1718651199353,"listedPrice":13.99,"stockholders":"8237人(较上一季度减少18.80%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾迪药业,688488,艾迪药业股票,艾迪药业股票老虎,艾迪药业股票老虎国际,艾迪药业行情,艾迪药业股票行情,艾迪药业股价,艾迪药业股市,艾迪药业股票价格,艾迪药业股票交易,艾迪药业股票购买,艾迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}